Skip to main content

Table 2 Identified metabolites of metabolomics study in patients with NSTEMI compared to STEMI

From: Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS

Metabolites

Fold

p value

Regulation (up/down)

Rtmed

l-leucine

105.8

1.19E−07

Down

6.48

l-isoleucine

28.4

6.91E−06

Down

5.31

l-proline

16

1.91E−05

Down

5.69

l-alanine

15

0.00018

Down

5.67

l-lysine

111.5

9.08E−09

Down

4.5

Glycine

2.3

3.17E−01

Down

11.7

l-valine

6.4

0.0001

Down

11.77

Malonic acid

14.5

88.8E−11

Down

12.32

Maleic acid

101.9

3.84E−05

Down

4.4

Butyric acid

25.3

1.33E−10

Down

12.22

l-lactic acid

189.5

1.73E−08

Down

3.64

Succinate

8.2

2.00E−10

Down

13.33

Urea

22.7

0.0001

Down

3.54

Creatine

34.6

1.59E−07

Down

3.64

Hidroxylamine

50.6

4.44E−11

Down

04.29

Carbamic acid

5.7

0.00001

Down

04.34

Betaine

89.5

1.73E−08

Down

03.64

Propyl alcohol

109.3

0.00004

Down

6.48

Isopropyl alcohol

10.2

0.00053

Down

6.57

Benzoic acid

103

0.00034

Down

7.57

LysoPC (18:1 (9Z))

1.5

0.00720

Down

13.13

Carnitine

137.9

7.69E−02

Down

03.89

Propane-1,3-diol

21.4

5.68E−08

Down

9.29

Stearic acid

3.8

6.44e−02

Up

11.53

LysoPC (18:0)

116.7

0.01

Up

11.93